Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Rhodes Pharmaceuticals L.P. with status Current. The shortage was first posted on Jan 11, 2024. Reported reason: Shortage of an active ingredient
Shortage details
- Status
- Current
- Company
- Rhodes Pharmaceuticals L.P.
- Package NDC
- 42858-167-01
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01)
- Initial Posting
- Jan 11, 2024
Reason
Shortage of an active ingredient